“Hampton University School of Pharmacy’s Doctor of Pharmacy program has been granted Precandidate status by the Accreditation Council for Pharmacy Education, 190 South LaSalle Street, Suite 3000, Chicago, IL 60603, 312/644-3575; FAX 866/228-2631, web site www.acpe-accredit.org

The Accreditation Council for Pharmacy Education (ACPE) accredits Doctor of Pharmacy programs offered by Colleges and Schools of Pharmacy in the United States and selected non-US sites. For a Doctor of Pharmacy program offered by a new College or School of Pharmacy, ACPE accreditation generally involves three steps: Precandidate status, Candidate status, and Accredited status.

Precandidate status denotes a developmental program that is expected to mature in accord with stated plans and within a defined time period. Precandidate status is awarded to a new program of a College or School of Pharmacy that has not yet enrolled students in the professional program and authorizes the school to admit its first class. Candidate status is awarded to a Doctor of Pharmacy program that is currently recognized by ACPE with Precandidate status and has students enrolled but has not yet had a graduating class. Accredited status is awarded to a program that has met all ACPE standards for accreditation and has graduated its first class. Graduates of a class designated as having Candidate status have the same rights and privileges of those graduates from an accredited program.

ACPE conveys its decisions to the various boards of pharmacy and makes recommendations in accord with its decisions. It should be noted, however, that decisions concerning eligibility for licensure by examination or reciprocity reside with the respective state boards of pharmacy in accordance with their state statutes and administrative rules.

The Doctor of Pharmacy program of the Hampton University School of Pharmacy was awarded Precandidate accreditation status during the January 24-26, 2024, meeting of the ACPE Board of Directors based upon an on-site evaluation conducted November 8-9, 2023, and discussion with University and School officials. Following the enrollment of the inaugural class of students in fall 2024, an on-site evaluation will be scheduled during academic year 2024-2025 for purposes of gathering additional information to be considered in the Board’s consideration of advancement to Candidate status. Based upon this evaluation, should the Board feel that Candidate status cannot be conferred, the School could respond to the Board’s concerns and reapply prior to the graduation of the first class. If Candidate status is not granted even after reapplication, graduates may not be eligible for licensure as pharmacists. If Candidate status is granted and the program continues to develop as planned, accredited status of the Doctor of Pharmacy program would be considered by the Board following the graduation of students from the program.